Requires DOH to maintain emergency stockpile of insulin and authorizes dispensing of emergency supply of insulin to certain patients.
Impact
The bill authorizes pharmacists to dispense emergency 30-day insulin supplies under specific conditions, such as having a prior prescription on record. These emergency supplies can be provided at a cost to the patient, who may also seek reimbursement through their health insurance plan. Importantly, individuals are limited to receiving one emergency insulin supply every twelve months unless a demonstrated need allows for additional support. This initiative aims to improve access to essential diabetes management equipment for those encountering hardships in maintaining their insulin prescriptions.
Summary
Senate Bill 2812 requires the New Jersey Department of Health (DOH) to maintain an emergency stockpile of insulin to assist residents whose supplies are running low before their next prescription can be acquired. The bill stipulates that the stockpile must include at least ten of the most commonly used insulin types among New Jerseyans, and mandates collaboration between the DOH and the Commissioner of Banking and Insurance to determine which types of insulin to maintain. Additionally, the DOH is tasked with assessing insulin needs and reevaluating its supply quarterly to ensure adequate availability, accounting for various factors including supply chain conditions and anticipated surges in demand.
Contention
While many support the bill for addressing critical gaps in diabetic care, there are concerns from some stakeholders about how the emergency supply framework may interact with existing health insurance plans. Critics fear that limiting emergency insulin access to once every twelve months might not adequately address all patients' needs, especially those with severe diabetes complications. Opponents may argue that while well-intentioned, the bill could create barriers for those with fluctuating insulin requirements, highlighting the need for a more comprehensive approach to diabetic healthcare and insurance coverage.